![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 30, 2011 10:58:39 PM
Among the many questions asked/answered in the forum are these about OvaDx:
What is the Arrayit OvaDx® Pre-Symptomatic Ovarian Cancer Test?
Arrayit Corporation has pioneered a new ovarian cancer screening test known as OvaDx®, which stands for ovarian cancer diagnosis. Based on the latest advances in life sciences technology, OvaDx® uses a sophisticated detection device known as a microarray to detect ovarian cancer as early as 5 years in advance of any overt disease symptoms. OvaDx® has been shown in research studies to detect stage IA tumors with high sensitivity and specificity.
What does OvaDx® detect?
OvaDx® detects a woman’s immune response, which is activated as soon as ovarian cancer cells begin to grow. The immune system identifies ovarian cancer cells as a abnormal condition in the body, and quickly activates an immune response to combat the illness. By measuring the immune response, OvaDx® is able to detect ovarian cancer much earlier than current tests.
How is the OvaDx® testing procedure performed?
OvaDx® is an advanced and non-invasive molecular diagnostics testing procedure. A few drops of blood are drawn and spun at high speed to collect the serum. A small amount of serum is then applied to an OvaDx® microarray to allow binding reactions to occur between the patient's serum molecules and capture agents on the OvaDx® testing substrate. Following the binding step, the test is stained with fluorescent molecules to visualize the captured molecules and a report is generated based on a scanned digital image. Samples that produce positive signals on OvaDx® are scored as positive for ovarian cancer whereas samples that fail to produce positive signals are scored as negative.
When will OvaDx® be available?OvaDx® is currently be used for research purposes only. OvaDx® as a clinical diagnostic test will be available to the public upon FDA approval.
http://arrayit.com/Microarray_Diagnostics/Ovarian_Cancer_Forum/ovarian_cancer_forum.html
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM